Brief: Innovative Pharmaceutical Biotech Posts HY loss Attributable To Owners Of Co Hk$146.7 Mln
Nov 29 (Reuters) - Innovative Pharmaceutical Biotech Ltd
0399.HK :
* HY LOSS FOR PERIOD ATTRIBUTABLE TO OWNERS OF COMPANY
HK$146.7
MILLION VERSUS LOSS HK$73.3 MILLION
* HY REVENUE HK$9.7 MILLION VERSUS HK$6.0 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS2hndPb
Further company coverage: 0399.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU